Medical vs Wellness Devices: What Really Makes the Difference?

MedDevice by Design with Mark Drlik and Ariana Wilson
Resources

Medical vs Wellness Devices: What Really Makes the Difference?

YouTube video thumbnail

The line between consumer wearables and regulated healthcare products is often unclear. In this episode of MedDevice by Design, Ariana Wilson and Mark Drlik break down medical vs wellness devices and explain why two products with identical hardware can fall into completely different regulatory categories.

Many people wear fitness trackers or smartwatches every day. However, not all of them are considered medical devices. Understanding the difference matters, especially for companies developing connected health technology or planning future regulatory pathways.

What Defines a Medical Device vs a Wellness Device

At its core, the difference between a medical device and a wellness device comes down to intended use and claims. Medical devices are designed to diagnose, treat, or mitigate disease. Wellness devices are not.

A product may collect the same type of data in both categories. However, once a company claims that the data can be used to diagnose or manage a medical condition, it crosses into medical device territory. At that point, regulatory clearance becomes mandatory.

Why Claims Matter More Than Hardware

One of the most important takeaways from this discussion is that hardware alone does not determine classification. Two devices can be technically identical. What changes everything is what the manufacturer says the device can do.

Wellness devices can report general information, such as activity or trends, without proving medical accuracy. Medical devices must demonstrate that their outputs are accurate, reliable, and trustworthy enough for clinical decision making. Because of this, regulators require evidence that clinicians can rely on the data.

Apple Watch vs Fitness Trackers as Real-World Examples

Despite the added complexity, many companies choose to pursue medical device clearance. Reimbursement is one major reason. Another is market expectation. Consumers increasingly expect devices to provide reliable medical insights, not just raw data.

That claim alone places it firmly in the medical device category. Without clearance, making such a claim could trigger regulatory warnings. Apple pursued clearance because it enables reimbursement opportunities and meets growing consumer expectations for actionable medical insights.

Why Companies Choose the Medical Device Path

For those seeking deeper guidance, the FDA provides clear documentation outlining what qualifies as a wellness device and what does not. This guidance also explains which marketing claims are permitted in each category.

Where to Learn More

For those seeking deeper guidance, the FDA provides clear documentation outlining what qualifies as a wellness device and what does not. This guidance also explains which marketing claims are permitted in each category.

MedTech engineers discussing prototype strategy while demonstrating a medical device form prototype during product development.

Ariana and Mark explore how prototype strategy helps teams reduce technical risk and accelerate progress.

Thumbnail with the words “Designing Out Bias” above an ECG waveform and a gloved hand holding a surgical instrument, highlighting bias in medical device design.

Ariana Wilson and Mark Drlik explore how bias can enter the development process and why engineers and manufacturers must actively work to prevent it.

FDA agentic AI reviewer concept with robotic hand reviewing medical device submission documents

The FDA agentic AI is making headlines after the agency announced its own internal AI review tool. In this episode of MedDevice by Design, Ariana and Mark discuss what this could mean for medical device submissions and regulatory efficiency.

Thumbnail showing gene therapy delivery challenge with disrupted DNA pathway

In this episode of MedDevice by Design, Ariana Wilson and Mark Drlik explore what sits beneath that progress, focusing on how these therapies are delivered and why delivery remains one of the hardest problems to solve.